Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial
Gerald S. Falchook*, Georgina V. Long, Razelle Kurzrock, Kevin B. Kim, Tobias H. Arkenau, Michael P. Brown, Omid Hamid, Jeffrey R. Infante, Michael Millward, Anna C. Pavlick, Steven J. O'Day, Samuel C. Blackman, C. Martin Curtis, Peter Lebowitz, Bo Ma, Daniele Ouellet, Richard F. Kefford
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
855
Link opens in a new tab
Citations
(Scopus)